The changing trends and outcomes in renal replacement therapy: Data from the ERA-EDTA Registry

Nephrology Dialysis Transplantation

Volumn 31, Issue 5, 2016, Pages 831-841

  Pippias, Maria ^a   Jager, Kitty J ^a   Kramer, Anneke ^a   Leivestad, Torbjørn ^b   Sánchez, Manuel Benítez ^c   Caskey, Fergus J ^d,e   Collart, Frederic ^f   Couchoud, Cécile ^g   Dekker, Friedo W ^h   Finne, Patrik ^i,j   Fouque, Denis ^k   Heaf, James G ^l   Hemmelder, Marc H ^m   Kramar, Reinhard ⁿ   De Meester, Johan ^o   Noordzij, Marlies ^a   Palsson, Runolfur ^p,q   Pascual, Julio ^r   Zurriaga, Oscar ^s,t   Wanner, Christoph ^u   Stel, Vianda S ^a   more..

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f French Speaking Belgium ESRD Registry   (Belgium)

^g AGENCE DE LA BIOMÉDECINE   (France)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^j Finnish Registry for Kidney Diseases   (Finland)

^k UNIVERSITÉ DE LYON   (France)

^l UNIVERSITY OF COPENHAGEN   (Denmark)

^m Nefrovisie Renine   (Netherlands)

ⁿ Austrian Dialysis and Transplant Registry   (Austria)

^o Dutch speaking Belgian Renal Registry ^*  (Belgium)

^p LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^q UNIVERSITY OF ICELAND   (Iceland)

^r HOSPITAL DEL MAR   (Spain)

^s Dirección General de Salud Pública   (Spain)

^t CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^u UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

more..

Author keywords

end stage renal disease; Europe; incidence; renal replacement therapy; survival

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DATA ANALYSIS; DISEASE REGISTRY; EUROPE; GEOGRAPHIC DISTRIBUTION; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RENOVASCULAR DISEASE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TREND STUDY; COHORT ANALYSIS; FEMALE; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MORTALITY; REGISTER; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TRENDS;

AGED; COHORT STUDIES; EUROPE; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RENAL REPLACEMENT THERAPY; TIME FACTORS;

EID: 84965108530     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv327     Document Type: Article

References (56)

1. Scribner BH, Caner JE, Buri R et al. the technique of continous hemodialysis. Trans Am Soc Artif Intern Organs 1960; 6: 88-103
2. van Dijk PC, Jager KJ, de Charro F et al. Renal replacement therapy in Europe: The results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001; 16: 1120-1129
3. Grace BS, Clayton P, McDonald SP. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy. Nephrology (Carlton) 2012; 17: 76-84
4. Kramer A, Stel V, Zoccali C et al. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dial Transplant 2009; 24: 3557-3566
5. Foley RN, Collins AJ. End-stage renal disease in the United States: an update from the United States Renal Data System. J AmSoc Nephrol 2007; 18: 2644-2648
6. Steenkamp R, Castledine C, Feest T. Chapter 6 Survival and causes of death of UK adult patients on renal replacement therapy in 2010: national and centre-specific analyses. Nephron Clin Pract 2012; 120 Suppl 1: c105-c135
7. den Hoedt CH, Bots ML, Grooteman MP et al. Should we still focus that much on cardiovascular mortality in end stage renal disease patients? The CONvective TRAnsport STudy. PLoS One 2013; 8: e61155
8. Vogelzang JL, van Stralen KJ, Jager KJ et al. Trend from cardiovascular to non-cardiovascular late mortality in patients with renal replacement therapy since childhood. Nephrol Dial Transplant 2013; 28: 2082-2089
9. ERA-EDTA-Registry: ERA-EDTA Registry Annual Report 2012. Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, 2014, pp. 119-126
10. Eurostat: http://epp.eurostat.ec.europa.eu/portal/page/portal/population/data/database (15 July 2013, date last accessed)
11. Kim HJ, Fay MP, Feuer EJ et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351
12. Noordzij M, Leffondre K, van Stralen KJ et al. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant 2013; 28: 2670-2677
13. Joinpoint Regression Program, Version 4.0.4-May 2013; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute. https://surveillance.cancer.gov/joinpoint/download (27 March 2014, date last accessed)
14. US Renal Data System. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013
15. Canadian Institute for Health Information. Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada. Toronto, ON: CIHI, 2014
16. Rosansky SJ, Clark WF, Eggers P et al. Initiation of dialysis at higher GFRs: is the apparent rising tide of early dialysis harmful or helpful? Kidney Int 2009; 76: 257-261
17. Stel VS, Tomson C, Ansell D et al. Level of renal function in patients starting dialysis: an ERA-EDTA Registry study. Nephrol Dial Transplant 2010; 25: 3315-3325
18. Lassalle M, Labeeuw M, Frimat L et al. Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survival. Kidney Int 2010; 77: 700-707
19. O'Hare AM, Choi AI, Boscardin WJ et al. Trends in timing of initiation of chronic dialysis in the United States. Arch InternMed 2011; 171: 1663-1669
20. Rosansky S, Glassock RJ, Clark WF. Early start of dialysis: A critical review. Clin J Am Soc Nephrol 2011; 6: 1222-1228
21. Cooper BA, Branley P, Bulfone L et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010; 363: 609-619
22. ClarkWF, Na Y, Rosansky SJ et al. Association between estimated glomerular filtration rate at initiation of dialysis and mortality. CMAJ 2011; 183: 47-53
23. Stel VS, Dekker FW, Ansell D et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant 2009; 24: 3175-3182
24. Kidney Disease: Improving Global Outcomes (KDIGO)CKDWork Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150
25. Nesrallah GE, Mustafa RA, ClarkWFet al. Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis. CMAJ 2014; 186: 112-117
26. Tattersall J, Dekker F, Heimburger O et al. When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study. Nephrol Dial Transplant 2011; 26: 2082-2086
27. Rosansky SJ, Clark WF. Has the yearly increase in the renal replacement therapy population ended? J Am Soc Nephrol 2013; 24: 1367-1370
28. Taube DH, Winder EA, Ogg CS et al. Successful treatment of middle aged and elderly patients with end stage renal disease. BMJ 1983; 286: 2018-2020
29. Kurella M, Covinsky KE,Collins AJ et al. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 2007; 146: 177-183
30. Thorsteinsdottir B, Montori VM, Prokop LJ et al. Ageism vs. the technical imperative, applying the GRADE framework to the evidence on hemodialysis in very elderly patients. Clin Interv Aging 2013; 8: 797-807
31. Williams AW, Dwyer AC, Eddy AA et al. Critical and honest conversations: The evidence behind the 'ChoosingWisely' campaign recommendations by the American Society of Nephrology. Clin J Am Soc Nephrol 2012; 7: 1664-1672
32. Collins AJ, Li S, Gilbertson DT et al. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl 2003; 87: S24-S31
33. Heaf JG, Wehberg S. Reduced incidence of end stage renal disease among the elderly in Denmark: an observational study. BMC Nephrol 2012; 13: 131
34. Chadban S, Howel M, Twigg S et al. National Evidence Based Guideline for Diagnosis, Prevention and Management of Chronic Kidney Disease in Type 2 Diabetes. Canberra: Diabetes Australia and the NHMRC, 2009
35. American Diabetes Association. Standards of medical care in diabetes- 2014. Diabetes Care 2014; 37 Suppl 1: S14-S80
36. James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet 2010; 375: 1296-1309
37. Kitada M, Kanasaki K, Koya D. Clinical therapeutic strategies for early stage of diabetic kidney disease. World J Diabetes 2014; 5: 342-356
38. LeCaire TJ, Palta M, Klein R et al. Assessing progress in retinopathy outcomes in type 1 diabetes: comparing findings from theWisconsin Diabetes Registry Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 2013; 36: 631-637
39. Clemens T, Michelsen K, Commers M et al. European hospital reforms in times of crisis: aligning cost containment needs with plans for structural redesign? Health Policy 2014; 117: 6-14
40. Lameire N, Van Biesen W, Vanholder R. Did 20 years of technological innovations in hemodialysis contribute to better patient outcomes? Clin J Am Soc Nephrol 2009; 4 Suppl 1: S30-S40
41. Knoll G. Trends in kidney transplantation over the past decade. Drugs 2008; 68 Suppl 1: 3-10
42. Maggiore U, Cravedi P. the marginal kidney donor. Curr Opin Organ Transplant 2014; 19: 372-380
43. Dominguez-Gil B, Haase-Kromwijk B, Van Leiden H et al. Current situation of donation after circulatory death in European countries. Transpl Int 2011; 24: 676-686
44. de Fijter JW. Counselling the elderly between hope and reality. Nephrol Dial Transplant 2011; 26: 2079-2081
45. Schaeffner ES, Rose C, Gill JS. Access to kidney transplantation among the elderly in the United States: A glass half full, not half empty. Clin J Am Soc Nephrol 2010; 5: 2109-2114
46. Roberts MA, Polkinghorne KR, McDonald SP et al. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis 2011; 58: 64-72
47. Nichols M, Townsend N, Scarborough P et al. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014; 35: 2929
48. Fliser D,Wiecek A, Suleymanlar G et al. the dysfunctional endothelium in CKDand in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda. Kidney Int Suppl 2011; 1: 6-9
49. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet 2013; 382: 339-352
50. Jager KJ, Lindholm B, Goldsmith D et al. Cardiovascular and noncardiovascular mortality in dialysis patients: where is the link? Kidney Int Suppl 2011; 1: 21-23
51. Maisonneuve P,Agodoa L,GellertRet al.Cancer in patients on dialysis for endstage renal disease: an international collaborative study. Lancet 1999; 354: 93-99
52. Winkelmayer WC, Owen W, Glynn RJ et al. Preventive health care measures before and after start of renal replacement therapy. J Gen Intern Med 2002; 17: 588-595
53. Tsakiris DJ, Stel VS, Finne P et al. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrol Dial Transplant 2010; 25: 1200-1206
54. Stengel B. Chronic kidney disease and cancer: A troubling connection. J Nephrol 2010; 23: 253-262
55. LameireN. Nephrotoxicity of recent anti-cancer agents. Clin Kidney J 2014; 7: 11-22
56. Vogelzang JL, van Stralen KJ,NoordzijMet al.Mortality frominfections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry. Nephrol Dial Transplant 2015; 30: 1028-1037